Zobrazeno 1 - 10
of 314
pro vyhledávání: '"J. G. Gribben"'
Autor:
Q. Heydt, C. Xintaropoulou, A. Clear, M. Austin, I. Pislariu, F. Miraki-Moud, P. Cutillas, K. Korfi, M. Calaminici, W. Cawthorn, K. Suchacki, A. Nagano, J. G. Gribben, M. Smith, J. D. Cavenagh, H. Oakervee, A. Castleton, D. Taussig, B. Peck, A. Wilczynska, L. McNaughton, D. Bonnet, F. Mardakheh, B. Patel
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
How the bone marrow microenvironment evolves during induction chemotherapy to facilitate acute lymphoblastic leukaemia (ALL) survival remains unclear. Here the authors show that adipocytes emergent during ALL therapy aid the survival of ALL cells thr
Externí odkaz:
https://doaj.org/article/5bd437ead45f4de29da3fc82c6989399
Autor:
Huang C; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Guangzhou Key Laboratory of Precise Diagnosis and Treatment of Biliary Tract Cancer, Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China., Huang X; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China., Qiu X; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China., Kong X; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China., Wu C; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China., Jiang X; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China., Yao M; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Department of Respiratory Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China., Wang M; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Department of Thoracic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China., Su L; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Guangdong Provincial Key Laboratory of Urological Diseases, Guangzhou Medical University, Guangzhou, 510120, China., Lv C; Clinical Biobank Center, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China., Wong PP; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.; Guangzhou Key Laboratory of Precise Diagnosis and Treatment of Biliary Tract Cancer, Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
Publikováno v:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Oct 22, pp. e2405130. Date of Electronic Publication: 2024 Oct 22.
Publikováno v:
The Journal of Immunology. 159:3156-3167
Since TCR-mediated stimulation induces T cells to become sensitive to Fas-mediated activation-induced cell death (Fas-AICD), we examined whether anergized and CD28-costimulated T cell clones were equally sensitive to Fas-AICD. Here, we show that TCR
Publikováno v:
Leukemia & Lymphoma. 22:53-64
Publikováno v:
Research in Immunology. 146:140-149
Autor:
J M, Munro, A S, Freedman, J C, Aster, J G, Gribben, N C, Lee, K K, Rhynhart, J, Banchereau, L M, Nadler
Publikováno v:
Blood. 83:793-798
The B-lymphocyte/accessory-cell activation antigen B7 (BB1) has been shown in vitro to stimulate T-lymphocyte proliferation and cytokine production via CD28 present on the latter cells. In this study, benign lymphoid tissues, lymphomas, and extralymp
Autor:
Jon C. Aster, Arnold S. Freedman, Lee M. Nadler, K Rhynhart, JM Munro, N Lee, J Banchereau, J. G. Gribben
Publikováno v:
Blood. 83:793-798
The B-lymphocyte/accessory-cell activation antigen B7 (BB1) has been shown in vitro to stimulate T-lymphocyte proliferation and cytokine production via CD28 present on the latter cells. In this study, benign lymphoid tissues, lymphomas, and extralymp
Autor:
Zhen, Linqing1,2 (AUTHOR), Tang, Xinlu1 (AUTHOR), Xu, Zhengguo3 (AUTHOR), Huang, Yizhou1,2 (AUTHOR), Qian, Xiaohua1,2 (AUTHOR), Lin, Haiping4 (AUTHOR), Li, Chao3 (AUTHOR), Cui, Rong5 (AUTHOR), Fang, Hongsheng6 (AUTHOR), Yang, Hao1,2 (AUTHOR), Qiu, Jiani1,2 (AUTHOR), Fang, Zhaoqi7 (AUTHOR), Peng, Xiaohuan1,2 (AUTHOR), Jin, Yifeng5 (AUTHOR), Nie, Jianing7 (AUTHOR), Guo, Shiwei3 (AUTHOR), Wang, Yuguang3 (AUTHOR), Zhong, Ming4 (AUTHOR) drzhongming1966@163.com, Gu, Hongchen1,2 (AUTHOR) hcgu@sjtu.edu.cn, Xu, Hong1,2 (AUTHOR) xuhong@sjtu.edu.cn
Publikováno v:
Advanced Science. 9/4/2024, Vol. 11 Issue 33, p1-16. 16p.
Autor:
Robert J. Soiffer, Pearl Leavitt, Donna Neuberg, Geraldine S. Pinkus, J. G. Gribben, K Pesek, Heather Daley, Arnold S. Freedman, SN Rabinowe, John F. Daley
Publikováno v:
Blood. 82:1366-1376
Twenty patients with poor prognosis B-cell chronic lymphocytic leukemia (B-CLL) underwent uniform high-dose chemoradiotherapy followed by rescue with multiple monoclonal antibody-purged autologous bone marrow (BM) (12 patients) or T-cell-depleted all
Autor:
Arnold S. Freedman, K Pesek, S D Woo, Claude D. Gimmi, Neil L. Spector, F Coral, Donna Neuberg, Laura Saporito, J. G. Gribben, Michael Barber
Publikováno v:
Blood. 81:3449-3457
Although molecular biologic techniques can now detect minimal numbers of residual cancer cells in patients in complete clinical remission, the clinical significance of minimal residual disease has never been conclusively established. If the detection